Add Yahoo as a preferred source to see more of our stories on Google. Medtronic has launched the Embrace Gynecology US investigational device exemption (IDE) study to evaluate the safety and ...
Add Yahoo as a preferred source to see more of our stories on Google. US-based robotics company Medical Microinstruments (MMI) has obtained an investigational device exemption (IDE) from the US Food ...
Medtronic Launches 3rd IDE Study for Hugo Robotic Surgery System, Targeting Gynecological Procedures
Medtronic has launched the Embrace Gynecology IDE U.S. clinical study to evaluate the Hugo robotic-assisted surgery system in robotic-assisted gynecological procedures. This marks the third IDE study ...
The two other U.S. IDE clinical studies — Expand URO and Enable Hernia Repair — both met their primary safety and effectiveness endpoints. Also, in July, positive results from a Medtronic-sponsored ...
EndoQuest will commence its PARADIGM clinical trial for endoluminal robotic colorectal surgery at five leading US hospitals in early 2025 Houston, TX, Dec. 10, 2024 (GLOBE NEWSWIRE) -- The US Food and ...
JACKSONVILLE, Fla., Nov. 05, 2025 (GLOBE NEWSWIRE) -- MMI (Medical Microinstruments, Inc.), a robotics company dedicated to increasing treatment options and improving clinical outcomes for patients ...
Company prepares to support clinical trial in the United States NEW BRUNSWICK, N.J., Nov. 12, 2024 /PRNewswire/ -- Johnson & Johnson MedTech, a global leader in cardiovascular, orthopaedic, surgery ...
BioWorld - Tuesday, November 11, 2025 See today's BioWorld MedTech Home » MMI gets IDE for robotic microsurgical study in Alzheimer’s To read the full story, subscribe or sign in.
First procedures completed and enrollment underway in Embrace Gynecology study, furthering the company's progress to expand minimally invasive treatment options to patients in the United States GALWAY ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results